Intravenous Immunoglobulin for Inflammatory Myositis in Rosedale, MD
The antibodies in human plasma, used in IVIg therapies, block the DM antibodies that damage the skin and muscles. IVIG can help slow down or stop the progression of inflammatory myositis, protecting muscular function and preventing more muscle damage by regulating the immune response and lowering inflammation. Intravenous immunoglobulin for myositis is available at Jean Walter Infusion Center. Visit our board-certified rheumatologists, Dr. Nasseri, MD, Dr. Landis, MD, Dr. Forghani, MD, and Dr. Talebi, MD, to enhance your quality of life. For more information, contact us today or book an appointment online now! We are conveniently located at 9114 Philadelphia Rd, Suite 208A, Rosedale, MD 21237.
Table of Contents:
How does IVIG work in treating myositis?
What types of myositis is IVIG used for?
What should patients consider before starting IVIG treatment for myositis?
IVIG, or intravenous immunoglobulin, helps manage myositis by relieving inflammation that causes muscle pain and weakness. Myositis is a chronic condition that occurs when the immune system mistakenly attacks the muscles, leading to chronic inflammation.
IVIG contains a mix of antibodies that are capable of regulating the immune system and suppressing the immune response, which is responsible for the body attacking its muscles. By reducing this inflammation, IVIG allows patients to participate more comfortably in physical movements and exercises that are necessary steps in their treatment for strengthening affected muscles.
IVIG can help facilitate the delivery of antibodies capable of limiting further muscle damage and supporting the immune system for better functionality. This anti-inflammatory effect significantly reduces muscle inflammation, making it easier for patients to adhere to other parts of their treatment plan. Although not a cure for myositis, IVIG helps manage symptoms and improve health outcomes, allowing individuals to manage their overall condition.
IVIG can also help patients adhere to recommended physical activities and exercises needed to strengthen the affected muscles by relieving the inflammation associated with myositis. This reduction in inflammation can significantly improve a patient’s quality of life, making it easier for them to engage in daily activities without pain. The treatment also supports better overall functionality and health outcomes, helping to manage the condition effectively over the long term.
IVIG is used to treat various types of myositis, including polymyositis, dermatomyositis, inclusion body myositis, and more. Each of these presenting conditions involves chronic muscle inflammation but may occur alongside varying symptoms with different degrees of severity.
To this end, the specific treatment dosage and schedule are customized based on the severity of the myositis symptoms, the patient’s health factors, and their response to the treatment.
While it does not cure myositis, IVIG is an excellent option to aid patients in the ongoing management of many different types of conditions, reducing symptoms and improving health outcomes.
By tailoring the treatment to individual needs, IVIG can provide effective symptom management for different types of myositis. Patients typically receive an initial dosage of IVIG administered intravenously over two to five days, followed by maintenance doses at slightly lower levels for several months.
By continually monitoring and adjusting the treatment, healthcare providers can optimize outcomes and help patients manage their symptoms more effectively over time.
Various considerations will be made ahead of IVIG treatment for myositis. Patients can expect to review all relevant information with providers at Jean Walter Infusion Center.
This will involve a discussion about any additional underlying health conditions as well as medication use and other influential factors. Providers at Jean Walter Infusion Center will work with each patient to outline a customized treatment plan, considering their unique needs and health circumstances.
Patients should consider that while IVIG is generally safe and well-tolerated, it may have side effects, including headaches, chills, and fever. Regular monitoring and ongoing assessments by healthcare providers are crucial to ensuring the treatment is effective and to making any necessary adjustments.
Patients should be prepared for regular infusion sessions and follow-up appointments to monitor their progress and adjust the treatment as needed. This ongoing treatment helps manage myositis effectively and achieve the best possible health outcomes.
IVIG will also typically be used as one component of comprehensive treatment interventions for myositis. However, in this respect, it is often able to improve patient participation in other aspects of their treatment plans to facilitate the best possible management of their condition.
IVIG may result in a reduction in muscle injuries and inflammation. Intravenous immunoglobulin for myositis is available at Jean Walter Infusion Center. For more information, contact us today or book an appointment online now! We are conveniently located at 9114 Philadelphia Rd, Suite 208A, Rosedale, MD 21237. We serve patients from Rosedale MD, Parkville MD, Middle River MD, Rossville MD, Overlea MD, and surrounding areas.